Crossmark

Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide

Crossref DOI link: https://doi.org/10.1038/s41409-017-0077-1

Published Online: 2018-01-16

Published Print: 2018-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Frangoul, Haydar

Evans, Misty

Isbell, Julie

Bruce, Katie

Domm, Jennifer
License Information

Text and Data Mining valid from 2018-01-16
More Information

Article History

Received: 21 August 2017

Revised: 30 November 2017

Accepted: 4 December 2017

First Online: 16 January 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below